These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3101393)

  • 1. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
    Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
    Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological study of glycolipoprotein isolated from extracellular slime of different Pseudomonas aeruginosa serogroups.
    Stanislavsky ES; Kholodkova EV; Youshkova NA; Yourokova IB; Zhvanetskaya MI
    Acta Microbiol Hung; 1986; 33(1):55-67. PubMed ID: 3092559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological study of Pseudomonas aeruginosa extracellular slime.
    Stanislavsky ES; Yushkova NA; Edvabnaya LS; Landsman NM; Zaidner IG
    Acta Microbiol Hung; 1985; 32(1):49-59. PubMed ID: 2412390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
    Sokalska M; Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective cross activity of the extracellular mucus of Pseudomonas aeruginosa].
    Stanislavskiĭ ES; Iushkova NA; Landsman NM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):72-7. PubMed ID: 6412492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common protective antigen (OEP) of Pseudomonas aeruginosa.
    Abe C; Shionoya H; Hirao Y; Okada K; Homma JY
    Jpn J Exp Med; 1975 Oct; 45(5):355-9. PubMed ID: 817054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological study of antisera to to artificial O-antigen of Pseudomonas aeruginosa.
    Edvabnaya LS; Stanislavskii ES; Lany B; Schiller B; Bichowicz I
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):163-8. PubMed ID: 6166668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
    Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
    Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
    Mates A; Zand P
    J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-forms of Pseudomonas aeruginosa. 3. The serological cross-reactions among stable L-forms of Pseudomonas aeruginosa, L-form of Streptococcus pyogenes and mycoplasmas.
    Yamamoto A; Homma JY
    Jpn J Exp Med; 1978 Dec; 48(6):545-51. PubMed ID: 108440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
    Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A
    Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slime glycolipoproteins and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection.
    Dimitracopoulos G; Bartell PF
    Infect Immun; 1980 Nov; 30(2):402-8. PubMed ID: 6777303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new scheme for additional typing of P. aeruginosa using antisera prepared against glycopolypeptide derived from the slime of the microorganisms.
    Nadaud M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Aug; 260(1):71-80. PubMed ID: 2414949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive hemagglutination reaction using formalinized sheep erythrocytes treated with tannic acid and coated with exotoxin of Pseudomonas aeruginosa.
    Takeshi K; Homma JY
    Jpn J Exp Med; 1978 Dec; 48(6):497-501. PubMed ID: 108439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein.
    Lynn M; Lotz L
    Br J Exp Pathol; 1984 Apr; 65(2):275-81. PubMed ID: 6424696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.